The effect of hemodialysis and acetate-free biofiltration on anemia

International Journal of Artificial Organs

Volumn 23, Issue 3, 2000, Pages 173-180

  Eiselt, Jaromir ^b   Racek, J ^a   Opatrny, K ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Department of Internal Medicine I ^*

Author keywords

Acetate free biofiltration; Anemia; Erythropoietin; Hemodiafiltration; Hemodialysis; Nutrition

Indexed keywords

ALUMINUM COMPOUNDS; ANTIOXIDANTS; BIOFILTERS; DIALYSIS; ENZYMES; FLAVONOIDS; HEMODIALYZERS; NUTRITION; PATIENT TREATMENT; PLANTS (BOTANY);

ACETATE-FREE BIOFILTRATION; ANEMIA; CHRONIC RENAL FAILURE; ERYTHROPOIETIN; HAEMODIALYSIS; HAEMOGLOBINS; HEMODIAFILTRATION; HEMOGLOBIN LEVELS; LOW FLUX; SUPEROXIDE DISMUTASES;

FREE RADICALS;

ALBUMIN; BICARBONATE; CALCIUM CARBONATE; CHOLINESTERASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; IRON; MALONALDEHYDE; PREALBUMIN; RECOMBINANT ERYTHROPOIETIN; SUPEROXIDE DISMUTASE; TRANSFERRIN;

ADULT; ANEMIA; ANTIOXIDANT ACTIVITY; ARTICLE; BIOFILTRATION; BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS MEMBRANE; DRUG INHIBITION; HEMODIALYSIS; HUMAN; LIPID PEROXIDATION; METABOLIC ACIDOSIS; NUTRITION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034000178     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880002300306     Document Type: Article

References (37)

1. Beusterien KM, Nissenson AR, Port FK, Kelly M, Steinwald B, Ware JE Jr. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 1996; 7: 763-73.
2. Grützmacher P, Bergmann M, Weinreich T et al. Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis. Contr Nephrol 1988; 66: 104-13.
3. Maiorca R, Brunori G, Zubani R et al. Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients. A longitudinal study. Nephrol Dial Transplant 1995; 10: 2295-305.
4. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15: 458-82.
5. Madore F, Lowrie E, Brugnara C. Anemia in hemodialysis patients: Variables affecting this outcome predictor. J Am Soc Nephrol 1997; 8: 1921-9.
6. Ifudu O, Feldman J, Friedman EA. The intensity of hemodialysis and the response ot erythropoietin in patients with end-stage renal disease. N Engl J Med 1996; 334: 420-5.
7. Kuwahara T, Markert M, Wauters JP. Neutrophil oxygen radical production by dialysis membranes. Nephrol Dial Transplant 1988; 3: 661-5.
8. Schmidtmann S, Muller M, von Baehr R, Precht K. Changes of antioxidative homeostasis in patients on chronic haemodialysis. Nephrol Dial Transplant 1991; 6 (suppl 3): S71-4.
9. Durak I, Akyol O, Basesme E, Canbolat O, Kavutcu M. Reduced erythrocyte defense mechanism against free radical toxicity in patients with chronic renal failure. Nephron 1994; 66: 76-80.
10. Jackson P, Loughrey CM, Lightbody JH, McNamee PT, Young LS. Effect of hemodialysis on total antioxidant capacity and serum antioxidants in patients with chronic renal failure. Clin Chem 1995; 41: 1135-8.
11. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-13.
12. 4 intoxication and vitamin E deficiency. Biochem Med 1980; 23: 302-11.
13. Albertazzi A, Palmieri PF, Mastrangelo E. Efficacy and tolerance of acetate free biofiltration: A central Italian multicenter trial. Kidney Int 1993; 44 (suppl 41): S188-94.
14. Movilli E, Camerini C, Zein H et al. A prospective comparison of bicarbonate dialysis, hemodiafiltration and acetate-free biofiltration in the elderly. Am J Kidney Dis 1996; 27: 541-7.
15. Verzetti G, Navino C, Bolzani R, Galli G, Panzetta G. Acetate-free biofiltration versus bicarbonate haemodialysis in the treatment of patients with diabetic nephropathy: a cross-over multicentric study. Nephrol Dial Transplant 1998; 13: 955-61.
16. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int 1999; 55: 286-93.
17. Maduell F, del Pozo C, Garcia H. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202-7.
18. Eiselt J, Opatrný K, Šefrna F, Malánová L, Bouda M, Opatrný K Jr. Effect of acetate-free biofiltration on anaemia and erythropoietin consumption. Čas Lék čes 1996; 135: 525-9
19. Hakim RM, Held PJ, Stannard DC. Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996; 50: 566-70.
20. Young EW. Dialysis dose, membrane type, and anemia control. Am J Kidney Dis 1998; 32 (suppl 4): S157-60.
21. Cheung AK, Hohnholt M, Leypoldt JK, De Spain M. Hemodialysis membrane biocompatibility: the case of erythropoietin. Blood Purif 1991; 9: 153-63.
22. Opatrný K Jr, Kroužecký A, Wirth J, Vit L, Eiselt J. The effects of a polyacrylonitrile membrane and a membrane made of regenerated cellulose on the plasma concentrations of erythropoietin during hemodialysis. Artif Organs 1998, 22: 816-20.
23. Schrander-v.d. Meer AM, ter Wee PM, Donker AJ, van Dorp WT. Dialysis efficacy during acetate-free biofiltration. Nephrol Dial Transplant 1998; 13: 370-4.
24. NKF-DOQI Clinical Practice Guidelines for Hemodialysis Adequacy. New York, National Kidney Foundation, 1997; M32-M37.
25. Lindsay RM, Spanner E, Heidenheim P, Kortas C, Blake PG. PCR, Kt/V and membrane. Kidney Int 1993; 43: S-268-73.
26. Walls J, Williams B. Metabolic role of acidosis in uraemia. Contrib Nephrol 1990; 81: 136-41.
27. Cutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995; 41: 1819-28.
28. Paul JL, Sall ND, Soni T et al. Lipid peroxidation abnormalities in hemodialyzed patients. Nephron 1993; 64: 106-9.
29. Canestrari F, Galli F, Giorgini A et al. Erythrocyte redox state in uremic anemia: effects of hemodialysis and revelance of glutathione metabolism. Acta Haematol 1994; 91: 187-93.
30. Eiselt J. Acetate-free biofiltration - Perspective replacement of renal function. Čas Lék čes 1995; 134: 445-9.
31. Eiselt J, Racek J, Holeček V, Opatrný K. Lipid peroxidation and antioxidant system in bicarbonate haemodialysis and acetate-free biofiltration. Vnitř Lék 1995; 41: 235-9.
32. Kuroda M, Asaka S, Tofuku Y, Takeda R. Serum antioxidant activity in uremic patients. Nephron 1985; 41: 293-8.
33. Kvičala J. Status and selenium intake as related to the thyroid gland in the population of Znojmo. Vnitř Lék 1996; 42: 738-42.
34. Eiselt J, Racek J, Holeček V, Opatrný K. Does plasmapheresis affect the formation of free radicals and the antioxidant system? Čas Lék čes 1996; 135: 558-62.
35. Hampel G, Schaller KH, Rosenmuller M et al. Selenium deficiency as contributing factor to anemia and thrombocytopenia in dialysis patients. Life Supp Syst 1985; 3 (suppl 1): S36-40.
36. Leung A, Henderson I, Fell G, Halls D, Kennedy AC. Selenium deficiency in chronic uraemia and dialysis. Proc. Eur Dial Transplant Assoc ERA 1985; 22: 1134-38.
37. Saint-Georges MD, Bonnefont DJ, Bourely BA et al. Correction of selenium deficiency in hemodialyzed patients. Kidney Int 1989; 36: (suppl. 27), S274-9.